NEW YORK (GenomeWeb News) – Shares of Caliper Life Sciences closed down more than 12 percent in Monday trade on the Nasdaq in advance of the release of its second-quarter results on Wednesday.
As reported Friday by GenomeWeb Daily News, Caliper’s stock had gained around 53 percent in the month of July, after it had declined steadily through the first half of the year.
The Hopkinton, Mass.-based manufacturer of in vivo and in vitro cell imaging systems is scheduled to release its second-quarter earnings report on Wednesday. Analysts estimate, on average, the Caliper will report revenues of $35.2 million and a loss per share of $.03.
Caliper’s shares finished the trading session Monday down 12.2 percent at $3.68.